Related Experiment Videos
Interleukin-6 serum levels in patients with multiple myeloma
C Emile1, J P Fermand, F Danon
1Immunology and Immunopathology Department, Hôpital Saint-Louis, Paris, France.
British Journal of Haematology
|February 1, 1994
Abstract:
Studying the prognostic value of serum interleukin-6 (IL-6) levels in multiple myeloma, we observed important daily variations in some patients. Therefore a unique serum IL-6 measurement should be interpreted with caution and requires confirmation by multiple determinations performed over a period of several days.